D-Wave Quantum (Quantum Annealing) vs Quantum-Si (Quantum Biology) — live market, SEC financial and quantum-hardware data side by side.
Direct verdict: QBTS vs QSI
QBTS leads this data snapshot on 3 of the five headline market, financial, runway, return and dilution measures with comparable data. The better investment still depends on valuation, technology execution and risk tolerance.
QBTS is the larger company at $5.43B market cap, about 20× the size of QSI ($265.67M).
QBTS reports more revenue ($24.59M vs $2.44M for QSI, latest fiscal year).
On cash runway — the metric that decides who needs to raise money first — QBTS is stronger (59mo vs 15mo).
QBTS vs QSI Performance (% return, all start at 0%)
Dual-platform: annealing utility today + gate-model roadmap — gate-model simulator beta launched October 2026; initial 17-qubit gate-model system targeted for 2026; 49 qubits in 2027; 181 qubits in 2028; 10 logical qubits in 2030; 100 logical qubits executing 1M+ operations by 2032 via dual-rail qubits
Proteus commercial launch targeted for Q2 2027 with a 20-amino-acid commercial kit; interim September 2026 data project approximately 60× more alignments per full run than Platinum Pro
Company
Founded
1999
2017
Headquarters
Burnaby, BC, Canada
Guilford, CT
Employees
382
145
Company DNA0–100 rank vs all tracked stocks · missing data = 0
Momentum = 1Y return · Scale = market cap · Runway capped at 36mo · Gov $ = federal awards · Research = citations + patents. Dollar axes use log scale.